These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 1664649

  • 1. [Clinical study of sparfloxacin, a new quinolone derivative, on urinary tract infection].
    Suzuki K, Horiba M, Naide Y, Shinoda M, Hibi H, Okishio N, Yanagioka M, Nagakubo I.
    Hinyokika Kiyo; 1991 Dec; 37(12):1749-57. PubMed ID: 1664649
    [Abstract] [Full Text] [Related]

  • 2. [Clinical efficacy of T-3262, a new quinolone compound, on urinary tract infection in 1988].
    Suzuki K, Nagata Y.
    Hinyokika Kiyo; 1989 Apr; 35(4):717-26. PubMed ID: 2735274
    [Abstract] [Full Text] [Related]

  • 3. [Clinical and bacteriological study of sparfloxacin on bacterial prostatitis].
    Suzuki K, Horiba M, Naide Y, Shinoda M, Hibi H.
    Hinyokika Kiyo; 1992 Jan; 38(1):121-8. PubMed ID: 1312292
    [Abstract] [Full Text] [Related]

  • 4. [Clinical efficacy of tosufloxacin on the patients with urinary tract infections].
    Yoshida K, Kobayashi N, Saitoh H, Negishi T, Yamada T, Watanabe T, Kawakami S, Tari K, Satake I, Ozawa K.
    Hinyokika Kiyo; 1992 Jan; 38(1):129-34. PubMed ID: 1546562
    [Abstract] [Full Text] [Related]

  • 5. [The dose-response study of sparfloxacin against skin and soft tissue structure infections in the field of surgery].
    Nakayama I, Yamaji E, Kawamura H, Kawaguchi H, Akieda Y, Suzuki T, Watanabe T, Itokawa K.
    Jpn J Antibiot; 1993 Aug; 46(8):706-25. PubMed ID: 8230738
    [Abstract] [Full Text] [Related]

  • 6. [Clinical studies on tosufloxacin (TFLX) in urology].
    Fukushima S, Moriyama M, Miyamoto H, Hosaka M, Kubota Y, Kinoshita Y, Noguchi K, Shuin T, Noguchi S, Yoshimura S.
    Hinyokika Kiyo; 1992 Apr; 38(4):501-6. PubMed ID: 1529827
    [Abstract] [Full Text] [Related]

  • 7. Rufloxacin once daily versus ofloxacin twice daily for treatment of complicated cystitis and upper urinary tract infections. Italian Multicentre UTI Rufloxacin Group.
    Mattina R, Cocuzza CE, Cesana M.
    Infection; 1993 Apr; 21(2):106-11. PubMed ID: 8387963
    [Abstract] [Full Text] [Related]

  • 8. [A clinical study of lomefloxacin on the patients with urinary tract infections--focused on lomefloxacin-induced photosensitivity reaction].
    Tozawa K, Washida H, Honma H, Kang K, Yamada Y.
    Hinyokika Kiyo; 1993 Sep; 39(9):801-5. PubMed ID: 8213373
    [Abstract] [Full Text] [Related]

  • 9. [Clinical study of ofloxacin (OFLX) on urinary tract infections].
    Miyata M, Inagaki N, Inada F, Yachiku S, Okamura K, Osanai H, Mizunaga M, Morikawa M.
    Hinyokika Kiyo; 1987 Aug; 33(8):1303-11. PubMed ID: 3480688
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of uncomplicated recurrent cystitis in women: lomefloxacin versus norfloxacin].
    Guibert J, Herman H, Capron MH.
    Contracept Fertil Sex; 1997 Jan; 25(1):79-84. PubMed ID: 9064058
    [Abstract] [Full Text] [Related]

  • 11. [The clinical and microbiological study of the preparation perfloxacin in treating urologic infections].
    Dragiev D, Savov E, Lilov A, Tsenova Z, Saltirov I, Atanasova I.
    Khirurgiia (Sofiia); 1993 Jan; 46(4):49-51. PubMed ID: 8041098
    [Abstract] [Full Text] [Related]

  • 12. Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women.
    Stein GE, Philip E.
    J Fam Pract; 1992 Feb; 34(2):180-4. PubMed ID: 1310715
    [Abstract] [Full Text] [Related]

  • 13. Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008).
    Matsumoto T, Hamasuna R, Ishikawa K, Takahashi S, Yasuda M, Hayami H, Tanaka K, Kiyota H, Muratani T, Monden K, Arakawa S, Yamamoto S.
    Int J Antimicrob Agents; 2011 Mar; 37(3):210-8. PubMed ID: 21242062
    [Abstract] [Full Text] [Related]

  • 14. [Dose finding study of sparfloxacin in single-dose therapy for female acute uncomplicated cystitis].
    Hirose T, Yoshiaki K, Yokoo A, Umehara T, Miyake M, Takatsuka K, Sato T, Miyamoto S, Tanaka N, Miyao N.
    Kansenshogaku Zasshi; 1992 Oct; 66(10):1462-72. PubMed ID: 1338088
    [Abstract] [Full Text] [Related]

  • 15. [Treatment with rufloxacin of complicated urinary tract infections].
    Carmignani G, Maffezzini M, Monti Bragadin C, Samer L, Gusmitta A, Cantoni L, Caglio G.
    Arch Ital Urol Nefrol Androl; 1992 Jun; 64(2):145-53. PubMed ID: 1324526
    [Abstract] [Full Text] [Related]

  • 16. Quinolones for short-term treatment of uncomplicated urinary tract infection.
    Kadiri S, Ajayi SO, Toki RA.
    East Afr Med J; 1999 Oct; 76(10):587-9. PubMed ID: 10734512
    [Abstract] [Full Text] [Related]

  • 17. [Clinical experience of norfloxacin in urinary tract infection].
    Banya Y, Funaki H, Takagane H, Tanji S, Abe T, Aoki H, Kubo T, Ohori T.
    Hinyokika Kiyo; 1985 Aug; 31(8):1501-17. PubMed ID: 4083210
    [Abstract] [Full Text] [Related]

  • 18. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group.
    Henry DC, Nenad RC, Iravani A, Tice AD, Mansfield DL, Magner DJ, Dorr MB, Talbot GH.
    Clin Ther; 1999 Jun; 21(6):966-81. PubMed ID: 10440621
    [Abstract] [Full Text] [Related]

  • 19. [Antimycobacterial activities of a new quinolone, sparfloxacin].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1991 Oct; 66(10):643-9. PubMed ID: 1660089
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y, Ozaki M, Matsuda M, Honmura T, Nishimura I, Yamaguchi R, Adachi T, Okawa Y, Nishino T.
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.